125 Cambridgepark Drive, Suite 203
24 articles with TriNetX
TriNetX Applauds House Appropriations Committee for Supporting Use of Real-World Evidence in House Agriculture-FDA Spending Bill
Praised the House Appropriations Committee for approving its fiscal year 2020 Agriculture, Rural Development, FDA, and Related Agencies bill which includes support for the use of RWE in regulatory decision making.
TriNetX to Present at ISPOR 2019 on the Power of Real-World Data to Impact Research Across a Wide Variety of Therapeutic Areas
TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that it will present eight posters at the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019 annual meeting to be held May 18-22 in New Orleans, Louisiana.
Hungary's University of Debrecen Joins TriNetX Network to Increase Collaboration and Growth in Commercial Clinical Studies
The University of Debrecen has joined the TriNetX global health research network to develop collaborative research partnerships with other healthcare organizations, improve visibility to pharmaceutical companies and contract research organizations conducting clinical trials and deliver greater access to clinical research opportunities to patients.
TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension
TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that the Journal of Clinical Hypertension has published its article on an analysis of first line treatment of essential hypertension using real-world data (RWD)
Company to Accelerate International Expansion and Further Investments in AI, Machine Learning, and Digital Clinical Trials
TriNetX Unveils Intuitive and Scalable Treatment Pathways Analytic Powered by Its Global Network of Longitudinal Real-World Data
TriNetX announced the release of its Treatment Pathways analytic, the latest self-service capability enhancing and simplifying the analysis of real-world data.
University Hospitals Cleveland Medical Center Leverages TriNetX to Assess Study Feasibility & Foster Research Collaborations
University Hospitals (UH) Cleveland Medical Center, a 1,032-bed, tertiary medical center in Northern Ohio, has joined the TriNetX global health research network
TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the creation of real-world evidence (RWE), today announced the results of a study confirming that the TriNetX platform successfully leverages real-world data (RWD) to generate RWE to replicate results from randomized clinical trials (RCTs).
TriNetX today announced new functionality that simplifies the way researchers conduct propensity score matching.
Harmonized and Integrated with Highly Intuitive Analytics for Use in Designing Protocols and Conducting Observational Research
Allergan, a leading global pharmaceutical company, has joined the TriNetX global health research network for real-time access to patient populations, driven and refreshed by clinical data, to determine protocol feasibility, cohort analysis and site identification.
Hadassah Medical Center to join the TriNetX global health research network to increase clinical trial activity and help pharmaceutical companies improve the protocol design and feasibility process.
Cardiovascular Research Consortium to Provide Access to Real-World Heart Care Data via the TriNetX Platform
The Cardiovascular Research Consortium (CRC) has selected TriNetX's real-world evidence platform to provide the biopharmaceutical industry with the first-of-its-kind access to extensive cardiology-specific clinical data.
Tartu University Hospital has joined the TriNetX global health research network, in an effort to grow its clinical trial participation internationally.
Enables Researchers to Hypothesize and Answer Complex Research Questions About Patient Outcomes & Treatment Effectiveness
Pfizer Joins the TriNetX Global Health Research Network Formed to Improve Clinical Trial Design and Accelerate the Development of New Drugs
Pfizer will have access to clinical data from TriNetX's network of healthcare organizations to support clinical study and protocol design, site identification, and patient recruitment for clinical trials across a range of therapeutic areas and development stages.
TriNetX is a network comprised of healthcare organizations representing nearly 100 million patients globally, biopharmaceutical companies, and CROs.
University of Iowa Health Care Increases Industry-Sponsored Clinical Trial Opportunities With TriNetX
In the first six months, UI Health Care was provided access to over 40 clinical trial opportunities from biopharmaceutical companies and CROs on the network.
TriNetX Unveils Natural Language Processing to Improve Protocol Design and Accelerate Identification of Patients for Clinical Trials
TriNetX's NLP service utilizes sophisticated algorithms to extract clinical facts from physician notes and clinical reports, links them with other Electronic Medical Record data, and makes the combined data available for assessing study feasibility, protocol design, site selection, and subsequent identification of patients for clinical trials.
The certification reinforces TriNetX's dedication to conducting best practices and its determination to provide the highest level of information security for its clients.